臓器チップ (Organ-on-a-Chip)：世界市場

世界の臓器チップ (Organ-on-a-Chip) の市場規模は、2024年の1億5,320万米ドルから、予測期間中はCAGR 33.6%で推移し、2029年末には6億5,190万米ドルに達すると予測されています。

北米市場は、2024年の6,750万米ドルから、予測期間中はCAGR 32.5%で推移し、2029年末には2億7,570万米ドルに達すると予測されています。欧州市場は、2024年の4,410万米ドルから、予測期間中はCAGR 35.1％で推移し、2029年末には1億9,880万米ドルに達すると予測されています。

当レポートでは、世界の臓器チップ (Organ-on-a-Chip) の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー
• 技術の進歩
• 成長推進因子
• セグメント分析
• 総論

第2章 市場概要

• 創薬における市場の潜在性
• サプライチェーン
• ポーターのファイブフォース分析
• 見通し

第3章 市場力学

• 市場力学スナップショット
• 市場促進要因
• 動物実験の代替手段
• パーソナライズ医療
• 市場抑制要因
• 標準化の欠如
• マルチ臓器チップの複雑さ
• 市場の課題
• 高コストと技術的専門知識の欠如
• 臨床段階の用途の少なさ
• 市場機会
• 製薬会社内のパートナーシップ
• 未開拓の組織および疾患モデル

第4章 規制状況

• 米国
• EU
• 中国
• 日本

第5章 新興技術

• サマリー
• ボディオンチップ
• AIと予測モデリング
• 3Dプリント
• 自動化と継続的な監視

第6章 市場セグメント分析

• セグメンテーションの内訳
• 製品・サービス
• 臓器チップ
• デバイス
• ソフトウェア
• サービス
• 市場分析：用途別
• 医薬品の発見と開発
• 毒性学調査
• 生理学的モデルの開発
• 市場分析：エンドユーザー別
• バイオテクノロジーおよび製薬会社
• 学術研究機関
• 化粧品会社
• その他
• 地理的内訳
• 市場分析：地域別
• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第7章 競合情報

• 競合分析
• パートナーシップ
• M&A活動
• 資金調達
• 特許情勢
• 特許レビュー：管轄別

第8章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• 4DCELL
• AXOSIM
• BEONCHIP
• BIOIVT
• BIOMIMX S.R.L.
• CHERRY BIOTECH
• CN BIO INNOVATIONS LTD.
• ELVEFLOW
• EMULATE INC.
• INSPHERO
• KIRKSTALL LTD.
• MIMETAS B.V.
• QURIS TECHNOLOGIES LTD.
• SYNVIVO INC.
• TISSUSE GMBH
• その他の主要企業

List of Tables

• Summary Table : Global Organ-on-a-Chip Market, by Region, Through 2029
• Table 1 : Advantages and Disadvantages of Commonly Used Materials for OoC Design
• Table 2 : Comparison of Organ-on-a-Chip with Traditional Drug Discovery Methods
• Table 3 : Raw Materials Manufacturers
• Table 4 : Porter's Five Forces Analysis of the Organ-on-a-Chip Industry
• Table 5 : Global Organ-on-a-Chip Market, by Product and Service, Through 2029
• Table 6 : Global Organ Chip Market, by Organ Number, Through 2029
• Table 7 : Global Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 8 : Global Liver-on-a-Chip Market, by Region, Through 2029
• Table 9 : Global Lung-on-a-Chip Market, by Region, Through 2029
• Table 10 : Global Heart-on-a-Chip Market, by Region, Through 2029
• Table 11 : Global Kidney-on-a-Chip Market, by Region, Through 2029
• Table 12 : Global Other Organ Chips Market, by Region, Through 2029
• Table 13 : Global Multi-organ Chips Market, by Region, Through 2029
• Table 14 : Global Organ-on-a-Chip Devices Market, by Region, Through 2029
• Table 15 : Global Organ-on-a-Chip Software Market, by Region, Through 2029
• Table 16 : Global Organ-on-a-Chip Services Market, by Region, Through 2029
• Table 17 : Global Organ-on-a-Chip Services Market, by Service Type, Through 2029
• Table 18 : Global Organ-on-a-Chip Standard Services Market, by Region, Through 2029
• Table 19 : Global Organ-on-a-Chip Custom Services Market, by Region, Through 2029
• Table 20 : Global Organ-on-a-Chip Market, by Application, Through 2029
• Table 21 : Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2021
• Table 22 : Global Organ-on-a-Chip Market in Drug Discovery and Development, by Region, Through 2029
• Table 23 : Global Organ-on-a-Chip Market in Toxicological Research, by Region, Through 2029
• Table 24 : Global Organ-on-a-Chip Market in Physiological Model Development, by Region, Through 2029
• Table 25 : Global Organ-on-a-Chip Market, by End User, Through 2029
• Table 26 : Global Organ-on-a-Chip Market for Biotechnology and Pharmaceutical Firms, by Region, Through 2029
• Table 27 : Cancer Research Grants in the U.S., by Cancer Type, as of July 2024
• Table 28 : Global Organ-on-a-Chip Market for Academic and Research Institutes, by Region, Through 2029
• Table 29 : Global Organ-on-a-Chip Market for Cosmetics Companies, by Region, Through 2029
• Table 30 : Global Organ-on-a-Chip Market for Other End Users, by Region, Through 2029
• Table 31 : Global Organ-on-a-Chip Market, by Region, Through 2029
• Table 32 : North American Organ-on-a-Chip Market, by Country, Through 2029
• Table 33 : North American Organ-on-a-Chip Market, by Products and Services, Through 2029
• Table 34 : North American Organ Chip Market, by Organ Number, Through 2029
• Table 35 : North American Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 36 : North American Organ-on-a-Chip Services Market, by Service Type, Through 2029
• Table 37 : North American Organ-on-a-Chip Market, by Application, Through 2029
• Table 38 : North American Organ-on-a-Chip Market, by End User, Through 2029
• Table 39 : U.S. Organ-on-a-Chip Market, Through 2029
• Table 40 : Canadian Organ-on-a-Chip Market, Through 2029
• Table 41 : Mexican Organ-on-a-Chip Market, Through 2029
• Table 42 : Organ-on-a-Chip Initiatives in Europe
• Table 43 : European Organ-on-a-Chip Market, by Country, Through 2029
• Table 44 : European Organ-on-a-Chip Market, by Product and Service, Through 2029
• Table 45 : European Organ Chip Market, by Organ Number, Through 2029
• Table 46 : European Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 47 : European Organ-on-a-Chip Service Market, by Service Type, Through 2029
• Table 48 : European Organ-on-a-Chips Market, by Application, Through 2029
• Table 49 : European Organ-on-a-Chips Market, by End User, Through 2029
• Table 50 : German Organ-on-a-Chip Market, Through 2029
• Table 51 : French Organ-on-a-Chip Market, Through 2029
• Table 52 : Italian Organ-on-a-Chip Market, Through 2029
• Table 53 : Spanish Organ-on-a-Chip Market, Through 2029
• Table 54 : U.K. Organ-on-a-Chip Market, Through 2029
• Table 55 : Rest of European Organ-on-a-Chip Market, Through 2029
• Table 56 : Asia-Pacific Organ-on-a-Chip Market, by Country, Through 2029
• Table 57 : Asia-Pacific Organ-on-a-Chip Market, by Products and Services, Through 2029
• Table 58 : Asia-Pacific Organ Chip Market, by Organ Number, Through 2029
• Table 59 : Asia-Pacific Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 60 : Asia-Pacific Organ-on-a-Chip Service Market, by Service Type, Through 2029
• Table 61 : Asia-Pacific Organ-on-a-Chip Market, by Application, Through 2029
• Table 62 : Asia-Pacific Organ-on-a-Chip Market, by End User, Through 2029
• Table 63 : Chinese Organ-on-a-Chip Market, Through 2029
• Table 64 : Japanese Organ-on-a-Chip Market, Through 2029
• Table 65 : Indian Organ-on-a-Chip Market, Through 2029
• Table 66 : Australian Organ-on-a-Chip Market, Through 2029
• Table 67 : South Korean Organ-on-a-Chip Market, Through 2029
• Table 68 : Rest of Asia-Pacific Organ-on-a-Chip Market, Through 2029
• Table 69 : South American Organ-on-a-Chip Market, by Product and Service, Through 2029
• Table 70 : South American Organ Chip Market, by Organ Number, Through 2029
• Table 71 : South American Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 72 : South American Organ-on-a-Chip Services Market, by Service Type, Through 2029
• Table 73 : South American Organ-on-a-Chip Market, by Application, Through 2029
• Table 74 : South American Organ-on-a-Chip Market, by End User, Through 2029
• Table 75 : MEA Organ-on-a-Chip Market, by Product and Service, Through 2029
• Table 76 : MEA Organ Chip Market, by Organ Number, Through 2029
• Table 77 : MEA Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
• Table 78 : MEA Organ-on-a-Chip Service Market, by Service Type, Through 2029
• Table 79 : MEA Organ-on-a-Chip Market, by Application, Through 2029
• Table 80 : MEA Organ-on-a-Chip Market, by End User, Through 2029
• Table 81 : Competitive Analysis of Organ-on-a-Chip Companies, by Tier
• Table 82 : Strategic Alliances in the Organ-on-a-Chip Industry, 2023-2025
• Table 83 : M&A in the Organ-on-a-Chip Industry, 2022-2024
• Table 84 : Funding and Grants for Organ-on-a-Chip Companies, 2022-2024
• Table 85 : Patents, by Jurisdiction, 2021-2024
• Table 86 : Active Patents of Leading Organ-on-a-Chip Companies, 2021-2024
• Table 87 : Report Sources
• Table 88 : Abbreviations Used in this Report
• Table 89 : 4Dcell: Company Snapshot
• Table 90 : 4Dcell: Product Portfolio
• Table 91 : AxoSim: Company Snapshot
• Table 92 : AxoSim: Product Portfolio
• Table 93 : AxoSim: News/Key Developments, 2023
• Table 94 : Beonchip: Company Snapshot
• Table 95 : Beonchip: Product Portfolio
• Table 96 : BioIVT: Company Snapshot
• Table 97 : BioIVT: Product Portfolio
• Table 98 : BioIVT: News/Key Developments, 2022-2024
• Table 99 : BiomimX S.r.l.: Company Snapshot
• Table 100 : BiomimX S.r.l.: Product Portfolio
• Table 101 : BiomimX S.r.l.: News/Key Developments, 2021
• Table 102 : Cherry Biotech: Company Snapshot
• Table 103 : Cherry Biotech: Product Portfolio
• Table 104 : CN Bio Innovations Ltd.: Company Snapshot
• Table 105 : CN Bio Innovations Ltd.: Financial Performance, FY 2022 and 2023
• Table 106 : CN Bio Innovations Ltd.: Product Portfolio
• Table 107 : CN Bio Innovations Ltd.: News/Key Developments, 2024 and 2025
• Table 108 : Elveflow: Company Snapshot
• Table 109 : Elveflow: Product Portfolio
• Table 110 : Elveflow: News/Key Developments, 2024
• Table 111 : Emulate Inc.: Company Snapshot
• Table 112 : Emulate Inc.: Product Portfolio
• Table 113 : Emulate Inc.: News/Key Developments, 2024
• Table 114 : InSphero: Company Snapshot
• Table 115 : InSphero: Product Portfolio
• Table 116 : InSphero: News/Key Developments, 2023 and 2024
• Table 117 : Kirkstall Ltd.: Company Snapshot
• Table 118 : Kirkstall Ltd.: Product Portfolio
• Table 119 : Mimetas B.V.: Company Snapshot
• Table 120 : Mimetas B.V.: Product Portfolio
• Table 121 : Mimetas B.V.: News/Key Developments, 2023
• Table 122 : Quris Technologies Ltd: Company Snapshot
• Table 123 : Quris Technologies Ltd.: Product Portfolio
• Table 124 : Quris Technologies Ltd.: News/Key Developments, 2022-2024
• Table 125 : SynVivo Inc.: Company Snapshot
• Table 126 : SynVivo Inc.: Product Portfolio
• Table 127 : TissUse GmbH: Company Snapshot
• Table 128 : TissUse GmbH: Product Portfolio
• Table 129 : Other Key Players in the Organ-on-a-Chip Industry

List of Figures

• Summary Figure : Global Organ-on-a-Chip Market Shares, by Region, 2023
• Figure 1 : Timeline of Organ-on-a-Chip Technology
• Figure 2 : Drug Development Process
• Figure 3 : Supply Chain of the Organ-on-a-Chip Industry
• Figure 4 : Organ-on-a-Chip Market Dynamics
• Figure 5 : Emerging Technologies in the Organ-on-a-Chip Market
• Figure 6 : Global Organ-on-a-Chip Market Shares, by Product and Service, 2023
• Figure 7 : Global Single-Organ-on-a-Chip Market Shares, by Organ Chip Type, 2023
• Figure 8 : Global Organ-on-a-Chip Market Shares, by Application, 2023
• Figure 9 : Global Organ-on-a-Chip Market Shares, by End User, 2023
• Figure 10 : Global Organ-on-a-Chip Market Shares, by Region, 2023
• Figure 11 : North American Organ-on-a-Chip Market Shares, by Country, 2023
• Figure 12 : European Organ-on-a-Chip Market Shares, by Country, 2023
• Figure 13 : Asia-Pacific Organ-on-a-Chip Market Shares, by Country, 2023
• Figure 14 : CN Bio Innovations Ltd.: Revenue Shares, by Business Unit, FY 2023
• Figure 15 : CN Bio Innovations Ltd.: Revenue Shares, by Country/Region, FY 2023

The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.

The North American Organ-on-a-Chip market is expected to grow from $67.5 million in 2024 and is projected to reach $275.7 million by the end of 2029, at a CAGR of 32.5% during the forecast period of 2024 to 2029.

The European Organ-on-a-Chip market is expected to grow from $44.1million in 2024 and is projected to reach $198.8 million by the end of 2029, at a CAGR of 35.1% during the forecast period of 2024 to 2029.

Report Scope:

This report analyzes trends in the global organ-on-a-chip (OoC) market. The market is segmented based on products and services, applications, end users, and regions. The application segment is characterized by drug discovery and development, toxicological research, and physiological model development. End-users include academic and research institutes, pharmaceutical and biotechnology companies, and the cosmetics industry. Products and services include organ chips, instruments, software, and services. Organ chips are further segmented into single-organ and multi-organ-on-a-chip products. The single-organ-on-a-chip products are further sub-segmented into liver, lung, heart, kidney, and other organs.

The report focuses on the major trends and challenges that affect the market and vendor landscape. It analyzes patents and emerging technologies related to the market. The report includes an analysis of the competitive landscape and industry structure and concludes with profiles of the leading companies.

In this report, the OoC market is segmented by geographical region into North America, Europe, Asia Pacific, South America, and the Middle East and Africa (MEA). The North American region consists of the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. The report covers global revenue ($ millions) for the base year of 2023, estimated data for 2024, and forecast values for 2025 through 2029.

Report Includes:

• 77 data tables and 53 additional tables
• Analyses of trends in the global organ-on-a-chip (OoC) market, with revenue data for 2021 to 2023, estimates for 2024, as well as projected CAGRs through 2029
• Estimates of the market size and revenue prospects for the global market, along with a market share analysis by product and service, application, end user and region
• Facts and figures pertaining to the market dynamics, technological progress, innovations, prospects, regulations and the impact of various macroeconomic factors
• A look at why organ-on-a-chip technology is gaining traction as an alternative to animal testing in life science research, toxicology testing and drug development studies
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Emulate Inc., Mimetas, TissUse GmbH, InSphero AG, and CN Bio Innovations Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Drivers of Growth
• Segmental Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Market Potential in Drug Discovery
• Supply Chain
• Raw Materials Suppliers
• Manufacturers
• Distributors
• End Users
• Porter's Five Forces Analysis
• Potential for New Entrants
• Threat of Substitutes
• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Degree of Competition
• Outlook

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Animal Testing Alternatives
• Personalized Medicine
• Market Restraints
• Lack of Standardization
• Complexity of multi-Organ-on-a-Chip
• Market Challenges
• High Cost and Lack of Technical Expertise
• Few Applications in Clinical Stages
• Market Opportunities
• Partnerships within Pharmaceutical Companies
• Unexplored Tissue and Disease Models

Chapter 4 Regulatory Landscape

• U.S.
• European Union
• China
• Japan

Chapter 5 Emerging Technologies

• Takeaways
• Body-on-a-Chip
• AI and Predictive Modeling
• 3D Printing
• Automation and Continuous Monitoring

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Products and Services
• Organ Chips
• Devices
• Software
• Services
• Market Analysis by Application
• Drug Discovery and Development
• Toxicological Research
• Physiological Model Development
• Market Analysis by End User
• Biotech and Pharmaceutical Companies
• Academic and Research Institutes
• Cosmetics Companies
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Competitive Analysis
• Partnerships
• M&A Activity
• Funding
• Patent Landscape
• Patent Review by Jurisdiction

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 4DCELL
• AXOSIM
• BEONCHIP
• BIOIVT
• BIOMIMX S.R.L.
• CHERRY BIOTECH
• CN BIO INNOVATIONS LTD.
• ELVEFLOW
• EMULATE INC.
• INSPHERO
• KIRKSTALL LTD.
• MIMETAS B.V.
• QURIS TECHNOLOGIES LTD.
• SYNVIVO INC.
• TISSUSE GMBH
• Other Key Players